The legal staff at Clark+Elbing consists of a nucleus of attorneys with advanced scientific degrees supported by a team of patent agents and technology specialists, each of whom holds a PhD in a scientific discipline.
We have unparalleled expertise in the biological and biochemical sciences, with professionals holding doctorates in such fields as chemistry, genetics, neuroscience, cell biology, developmental biology, molecular biology, neurobiology, and pharmacology.
Please click on a name above to view that individual's biography.
JD, Northeastern University
MS Biology, Northeastern University
AB English, Case Western Reserve University
Registered to practice before the U.S. Patent and Trademark Office
Admitted to practice in Massachusetts state and Federal courts
Paul Clark founded the firm Clark+Elbing along with Karen Elbing in 1996 and was a Partner until 2017. Previously Paul practiced law at Fish & Richardson P.C., as an Associate from 1979 to 1986, and as a Partner from 1986 to 1996. His practice involves advising clients in the biotechnology and pharmaceutical areas on complex intellectual property matters, as well as prosecuting patent applications, licensing, interference practice, re-examination practice, and the preparation of patentability, non-infringement, and invalidity opinions.
Paul has worked in virtually every area of biotechnology, including the discovery of small molecule therapeutics for the treatment of major medical disorders, recombinant proteins, gene therapy, and stem cell technology. He also has extensive experience in handling the intellectual property issues that arise during due diligence, attendant to private financings and IPOs.
Paul obtained the first patent on a transgenic animal, the Harvard Mouse. He is the author or co-author of numerous presented papers and articles on biotechnology patent law.